Navigation Links
SurgiCount Medical Launches New Surgical Sponge Product
Date:3/4/2013

IRVINE, Calif., March 4, 2013 /PRNewswire/ -- SurgiCount Medical, Inc., the wholly-owned operating subsidiary of Patient Safety Technologies, Inc. (OTCBB: PSTX), today announced it is introducing a new proprietary surgical sponge at the upcoming Association of periOperative Registered Nurses (AORN) 60th Congress March 3-7 in San Diego, California. The patent protected SAFE-T Lap is designed to allow for improved visibility during surgery and enhanced X-ray detectability.

"The SAFE-T Lap is a simple, innovative product designed to provide users of the Safety-Sponge® System an added layer of protection and improved ease of use," stated Brian E. Stewart , President and Chief Executive Officer of Patient Safety Technologies, Inc. "Based on customer insight and demand for a surgical sponge that is more visible both during use and on X-ray, we look forward to introducing this line of lap sponges."

The SurgiCount Safety-Sponge® System is clinically proven to help eliminate retained surgical sponges[1] and decrease the occurrences of misplaced and miscounted sponges[2], enabling hospitals to perform fewer X-rays related to this issue. The SAFE-T Lap is designed to provide a more easily visible lap sponge both during use in surgery and for those times when the established clinical standard of an X-ray is the best course of action for the safety of the patient.

Additional information regarding the SAFE-T Lapcan be found here: http://scmd.com/safe-t-lap/.

The new SAFE-T Lap product will be introduced at the upcoming AORN 60th Congress March 3-7 in San Diego, CA in SurgiCount Medical's booth #462. For more information about the SAFE-T Lap or the Safety-Sponge® System contact SurgiCount Medical at (949) 387-2277 or send an email to inquiries@scmd.com.

About Patient Safety Technologies, Inc. and SurgiCount Medical
Patient Safety Technologies, Inc., through its wholly-owned operating subsidiary SurgiCount Medical, Inc., provides the Safety-Sponge® System, a solution clinically proven to improve patient safety and reduce healthcare costs by helping eliminate one of the most common errors in surgery, retained surgical sponges. The market leading retained sponge prevention solution, the Safety-Sponge® System is used in more than 285 government, teaching and community hospitals across the U.S., including 7 of the U.S. News and World Report Best Hospital Honor Roll recipients, representing more total users and more Honor Roll users than all retained sponge prevention solutions combined. For more information, contact SurgiCount Medical, Inc. at (949) 387-2277 or visit www.surgicountmedical.com.

[1] Cima RR, Kollengode A, Garnatz J, et al. Incidence and characteristics of potential and actual retained foreign object events in surgical patients. J Am Coll Surg 2008;207:80-87
[2] Greenberg CC, Gawande AA, et al. Bar-coding Surgical Sponges to Improve Safety: A Randomized Controlled Trial. Annals of Surg 2008; V 247, No. 4, 612-616


'/>"/>
SOURCE SurgiCount Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. SurgiCount Medical Awarded Contract From HealthTrust Purchasing Group for the Safety-Sponge® System
2. SurgiCount Medical Achieves Landmark Product Usage And Customer Milestones
3. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
4. Medical Device Developers - Network at BIOMEDevice Boston Next Week
5. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
6. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
7. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
8. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
9. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
10. Essential Medical Dismisses Patent Case against Masimo and Cercacor
11. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/22/2017)... -- AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN ... with the widespread pain associated with fibromyalgia in the ... Essex, England commented, "I had difficulty ... sleep at all, tremendous pain, with every movement sending ... AVACEN 100] enough, how this has and is helping ...
Breaking Medicine Technology:
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):